The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
![p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram](https://www.researchgate.net/publication/9012549/figure/fig3/AS:280591447674880@1443909622094/p63-IHC-analysis-with-4A4-antibody-in-lung-tumorigenesis-A-bronchial-epithelium.png)
p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram
![A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-013-1488-z/MediaObjects/428_2013_1488_Fig1_HTML.gif)
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink
![Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies](https://www.frontiersin.org/files/Articles/873994/fonc-12-873994-HTML/image_m/fonc-12-873994-g001.jpg)
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
![A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-020-01018-7/MediaObjects/13000_2020_1018_Fig1_HTML.png)
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text
![Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5044754/bin/nihms783141f1a.jpg)
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC
![Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1807593222005683-gr2.jpg)
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? - ScienceDirect
![Cureus | Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study | Article Cureus | Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study | Article](https://assets.cureus.com/uploads/figure/file/521198/article_show_eb0ec7d0808a11ed980811de8cc3595b-IHC-Staining.webp)
Cureus | Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study | Article
![TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.3800629/MediaObjects/41379_2006_Article_BF3800629_Fig1_HTML.jpg)
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
![Frontiers | Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases Frontiers | Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases](https://www.frontiersin.org/files/Articles/619371/fonc-11-619371-HTML/image_m/fonc-11-619371-g001.jpg)
Frontiers | Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases
![p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents](https://enquirebio.com/wp-content/uploads/2018/06/enQuire-Bio-8626-MSM8-P0-anti-p63-Squamous-Basal-Myoepithelial-Cell-Marker-antibody.jpeg)
p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
![p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-021-00260-5/MediaObjects/40364_2021_260_Fig1_HTML.png)
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
![TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800629/MediaObjects/41379_2006_Article_BF3800629_Fig3_HTML.jpg)
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
![p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2011.173/MediaObjects/41379_2012_Article_BFmodpathol2011173_Fig5_HTML.jpg)
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology
![Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations - ScienceDirect Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213294515001556-gr1.jpg)
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations - ScienceDirect
![Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit](https://pub.mdpi-res.com/diagnostics/diagnostics-10-00025/article_deploy/html/images/diagnostics-10-00025-g005.png?1581046508)
Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
![p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40364-021-00260-5/MediaObjects/40364_2021_260_Fig2_HTML.png)